Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Clinical trial NCT04977375 · RECRUITING
Trial details
- NCT number
- NCT04977375
- Sponsor
- Chirag G. Patil
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2025-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.